Skip to main content

Radioactive Drug Research Committee

  • Evaluates research applications involving the use of radioactive drugs intended to obtain basic information regarding the metabolism of a radioactively labeled drug or regarding human physiology, pathophysiology, or biochemistry, but not intended for immediate therapeutic, diagnostic, or similar purposes or to determine the safety and effectiveness of the drug in humans for such purposes as defined by the FDA.
  • Reviews, and has the authority to approve, require modification in, or disapprove all research activities that fall within its jurisdiction.